This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The University of Texas System. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,696 
2 out of 5,638 
Years Active: 2010-2011
Title: Gonzalo E Laje: Innovator in Antidepressant Treatment
Introduction
Gonzalo E Laje is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of mental health through his innovative approaches to antidepressant treatment. With a total of 2 patents, Laje's work focuses on identifying patients at risk of adverse events during treatment and predicting treatment outcomes.
Latest Patents
Laje's latest patents include methods that enhance the safety and efficacy of antidepressant medications. One patent outlines a method to identify patients at risk of developing treatment-emergent suicidal ideation. This invention involves obtaining a sample of genetic material from patients and assaying it for specific genotypes associated with increased risk. The genotypes are characterized by polymorphisms in genes such as glutamine receptor, ionotropic, kainate 2 (GRIK2) and glutamate receptor ionotropic AMPA 3 (GRIA3).
Another significant patent provides a method for predicting the outcome of treatment with antidepressant medication. This method screens patients to identify those with a decreased risk of non-response to treatment. It involves obtaining a genetic sample and assaying it for genotypes linked to a better response to antidepressant medications, specifically focusing on genes like HTR2A, GRIK4, and BCL2.
Career Highlights
Throughout his career, Gonzalo E Laje has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Texas System. His work in these institutions has allowed him to contribute to significant advancements in mental health treatment.
Collaborations
Laje has collaborated with esteemed colleagues such as Francis J McMahon and Silvia Paddock. These collaborations have further enriched his research and innovations in the field of antidepressant treatment.
Conclusion
Gonzalo E Laje's contributions to the field of mental health through his patents and collaborations highlight his commitment to improving patient outcomes in antidepressant treatment. His innovative methods pave the way for safer and more effective treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile